Evaluation of the Effect of Multiple Dosing With BI 201335 on CYP2B6 Metabolism and Effect of Multiple Dosing With Efavirenz on the Steady-state Pharmacokinetics of BI 201335 and on CYP3A4/5 Metabolism in Healthy Volunteers
Clinical trial NCT01371006 · COMPLETED
Trial details
- NCT number
- NCT01371006
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2011-09-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.